Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines

NCT00254917 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Polio
Pertussis
Haemophilus Influenzae Type B

Interventions

BIOLOGICAL: Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine
BIOLOGICAL: Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine

Sponsor

Sanofi